In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 03, 2018

    DOJ Looks To Help Resolve Opioid MDL As Friend Of Court

    The U.S. Department of Justice sought Monday to step into multidistrict litigation alleging opioid manufacturers overstated the drugs' benefits and downplayed risks when marketing them to doctors, looking to help craft nonmonetary settlements to aid the public and reimburse the government for treatment of users.

  2. March 28, 2018

    Judge OKs Drug Distributor Info Sharing In Opioid MDL

    The Ohio federal judge overseeing the opioid multidistrict litigation on Tuesday signed off on a order proposed by three drug distributors that sharing information about suspicious drug orders in settlement negotiations is immune from federal antitrust law.

  3. March 07, 2018

    Opioid MDL To Get Litigation Track Amid Settlement Talks

    Multidistrict litigation over the opioid crisis will enter an active stage of discovery, motions and bellwether trials to boost the prospects of ongoing settlement talks, an Ohio federal judge said Wednesday.

  4. March 07, 2018

    What Happens If The DOJ Joins The Opioid MDL?

    If the U.S. Department of Justice enters multidistrict litigation about the opioid crisis, it could strengthen the negotiating position of local governments but also siphon off some of the money they seek, plaintiffs lawyers say.

  5. March 05, 2018

    DEA Agrees To Large Data Release In Opioid MDL

    The U.S. Drug Enforcement Administration on Monday told an Ohio federal judge presiding over multidistrict litigation that it will divulge nine years of data on opioid sales, backing off its resistance to such a large data release.

  6. March 01, 2018

    'Revolving Door' At DEA Faces Scrutiny In Opioid MDL

    The U.S. Drug Enforcement Administration's resistance to divulging information about opioid sales as part of multidistrict litigation is generating fresh scrutiny of its "revolving door" relationship with drug companies and law firms.

  7. March 01, 2018

    Details Emerge On DEA Data Release In Opioid MDL

    The U.S. Drug Enforcement Administration will divulge two years of information about drugmakers that sold the vast majority of opioids in every state, an Ohio federal judge presiding over multidistrict litigation said Thursday.

  8. February 23, 2018

    Opioid MDL Attys Clash With DEA Over Drug Data

    Attorneys targeting drug manufacturers and distributors in multidistrict litigation over the opioid crisis are clashing with the U.S. Drug Enforcement Administration regarding access to vast amounts of government data on painkiller sales, according to filings in Ohio federal court on Friday.

  9. February 20, 2018

    Meet The Attys At The Opioid MDL's Negotiating Table

    The fate of multidistrict litigation over the opioid crisis now rests heavily with 18 elite attorneys who've been tasked with negotiating a settlement in the historic case. Here, Law360 presents the names and faces of the negotiators, along with information about their biggest cases and notable achievements.

  10. February 07, 2018

    Atty Negotiating Teams Set In Opioid MDL

    An Ohio federal judge on Wednesday created negotiating teams for attorneys in sprawling multidistrict litigation over allegedly reckless opioid sales, the latest move to steer the massive case toward settlement.